Population Pharmacokinetics of Temocillin Administered by Continuous Infusion in Patients with Septic Shock Associated with Intra-Abdominal Infection and Ascitic Fluid Effusion
Temocillin is active against Gram-negative bacteria, including many extended-spectrum β-lactamase (ESBL)-producing Enterobacterales. We studied its pharmacokinetics in plasma and ascitic fluid after intravenous administration of a loading dose of 2 g over 30 min, followed by continuous infusion of 6...
Main Authors: | Perrin Ngougni Pokem, Xavier Wittebole, Christine Collienne, Hector Rodriguez-Villalobos, Paul M. Tulkens, Laure Elens, Françoise Van Bambeke, Pierre-François Laterre |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-07-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/11/7/898 |
Similar Items
-
Temocillin: Applications in Antimicrobial Stewardship as a Potential Carbapenem-Sparing Antibiotic
by: Tommaso Lupia, et al.
Published: (2022-04-01) -
Clinical Efficacy of Temocillin Standard Dosing in Patients Treated with Outpatient Antimicrobial Therapy
by: Evelyne Van den Broucke, et al.
Published: (2022-10-01) -
Lymphatic Malformation Presenting as Recurrent Pleural Effusion and Ascites
by: Sarath Balaji, et al.
Published: (2022-01-01) -
A rare cause of pericardial effusion and ascites: POEMS syndrome
by: Bilal Katipoglu, et al.
Published: (2017-12-01) -
Extracorporal modified ascitic fluid reinfusion in treatment of resistant ascites in liver cirrhosis
by: I. E. Onnintsev, et al.
Published: (2017-06-01)